Gara Jalqabaatti › Kansara Metastatikii › California › San Diego
Qorannoo klinikaalii Kansara Metastatikii San Diego, CA keessatti
Qorannoo 30 Kansara Metastatikii f San Diego fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- University of California San Diego, San Diego
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · Miili 11 fagaatti
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Diego Moores Cancer Center, San Diego
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- ALX Center 9, La Jolla · Miili 11 fagaatti
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Medical Center - Rancho Bernardo, San Diego
- fi 3 dabalataa
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- UC San Diego Medical Center - Bankers Hill, San Diego
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- fi 5 dabalataa
Intratumoral N17350 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Namoota walitti qabaa jiraSadarkaa 3
- Moores Cancer Center, La Jolla · Miili 11 fagaatti
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- UC San Diego Medical Center - Bankers Hill, San Diego
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- fi 5 dabalataa
NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of California - San Diego, La Jolla · Miili 11 fagaatti
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Namoota walitti qabaa jiraSadarkaa 3
- UC San Diego, San Diego
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Diego, Moores Cancer Center, San Diego
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Namoota walitti qabaa jiraSadarkaa 1
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, La Jolla · Miili 11 fagaatti
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Investigative Site #101, La Jolla · Miili 11 fagaatti
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Investigative Site #101, San Diego
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 2
- University of California, San Diego, La Jolla · Miili 11 fagaatti
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Diego Moores Cancer Center, San Diego
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Namoota walitti qabaa jiraSadarkaa 2/3
- UC San Diego Moores Cancer Center, La Jolla · Miili 11 fagaatti
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · Miili 11 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, La Jolla · Miili 11 fagaatti
A Beta-only IL-2 ImmunoTherapY Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Sharp Memorial Hospital, San Diego
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Diego, San Diego
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Washington, DCQorannoo 43
- Dallas, TXQorannoo 42
Qorannoo biroo San Diego keessatti
- Kansara Qara'a Non-Small CellQorannoo 48
- Saree OljooQorannoo 41
- Saree (Gosoota Hunda)Qorannoo 32
- Kansarii ProstateQorannoo 31
- Kansarii ColorectalQorannoo 25
- Kansarii OvariiQorannoo 24
- Kansarii PancreasQorannoo 24
- Dhibee QaraQorannoo 23
- ObesityQorannoo 23
- Cufama OnneeQorannoo 23
- DepreshiniiQorannoo 21
- MelanomaQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.